{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:47:42Z","timestamp":1790966862764,"version":"4.1.0"},"reference-count":35,"publisher":"American Academy of Pediatrics (AAP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,11,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To evaluate the efficacy of oral penicillin V and intramuscular benzathine penicillin G (BPG) in eradicating group A streptococci from the upper respiratory tract.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology.<\/jats:title><jats:p>Two randomized, single-blind, multicenter antibiotic efficacy trials in children using recommended doses of either oral penicillin V or intramuscular BPG for treatment of acute-onset pharyngitis associated with isolation of group A streptococci were conducted. Throat examinations and cultures were obtained at enrollment and on days 5 to 8, 10 to 14, and 29 to 31.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Thirty-five percent of 284 evaluable patients treated with oral penicillin V and 37% of BPG-treated patients were microbiologic treatment failures at either 10 to 14 or 29 to 31 days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>Although these findings do not provide sufficient evidence to change current treatment recommendations or public health policy, important questions are raised about currently recommended penicillin doses, about the role of the carrier state, and possibly about adequate bioavailability of intramuscular BPG. These findings require confirmation.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.108.5.1180","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"1180-1186","source":"Crossref","is-referenced-by-count":107,"title":["Unexplained Reduced Microbiological Efficacy of Intramuscular Benzathine Penicillin G and of Oral Penicillin V in Eradication of Group A Streptococci From Children With Acute Pharyngitis"],"prefix":"10.1542","volume":"108","author":[{"given":"Edward L.","family":"Kaplan","sequence":"first","affiliation":[{"name":"1 From the Department of Pediatrics and the World Health Organization Collaborating Center for Reference and Research on Streptococci, University of Minnesota Medical School, Minneapolis, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dwight R.","family":"Johnson","sequence":"additional","affiliation":[{"name":"1 From the Department of Pediatrics and the World Health Organization Collaborating Center for Reference and Research on Streptococci, University of Minnesota Medical School, Minneapolis, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,11,1]]},"reference":[{"key":"2021121003550012200_B1"},{"key":"2021121003550012200_B2","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/01.CIR.78.4.1082","article-title":"Prevention of rheumatic fever: a statement for health professionals by the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease of the Council on Cardiovascular Disease in the Young, the American Heart Association.","volume":"78","author":"Dajani","year":"1988","journal-title":"Circulation"},{"key":"2021121003550012200_B3"},{"key":"2021121003550012200_B4","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1086\/513768","article-title":"Diagnosis and management of group A streptococcal pharyngitis: a practice guideline.","volume":"25","author":"Bisno","year":"1997","journal-title":"Clin Infect Dis"},{"key":"2021121003550012200_B5","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(80)91832-2","article-title":"Failure of penicillin to eradicate group A streptococci during an outbreak of pharyngitis.","volume":"2","author":"Gastanaduy","year":"1980","journal-title":"Lancet."},{"key":"2021121003550012200_B6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S0022-3476(89)80352-X","article-title":"Pharmacokinetics of benzathine penicillin G: serum levels during the 28 days after intramuscular injection of 1,200;000 units.","volume":"115","author":"Kaplan","year":"1989","journal-title":"J Pediatr"},{"key":"2021121003550012200_B7","first-page":"17","article-title":"Differences in serum penicillin concentrations following intramuscular injection of benzathine penicillin G from different manufacturers.","volume":"2","author":"Zaher","year":"1992","journal-title":"J Pharm Med"},{"key":"2021121003550012200_B8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1542\/peds.97.6.976","article-title":"Adherence to physician's instructions as a factor in managing streptococcal pharyngitis.","volume":"97","author":"Dajani","year":"1996","journal-title":"Pediatrics"},{"key":"2021121003550012200_B9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0002-9343(51)90336-1","article-title":"Prophylaxis of acute rheumatic fever by treatment of the preceding streptococcal infection with various amounts of depot penicillin.","volume":"10","author":"Wannamaker","year":"1951","journal-title":"Am J Med"},{"key":"2021121003550012200_B10","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1093\/clind\/15.Supplement_1.S62","article-title":"General guidelines for the evaluation of new anti-infective drugs for the treatment of respiratory tract infections.","volume":"15","author":"Chow","year":"1992","journal-title":"Clin Infect Dis"},{"key":"2021121003550012200_B11"},{"key":"2021121003550012200_B12","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/infdis\/123.5.490","article-title":"Diagnosis of streptococcal pharyngitis: differentiation of active infection from the carrier state in the symptomatic child.","volume":"123","author":"Kaplan","year":"1971","journal-title":"J Infect Dis"},{"key":"2021121003550012200_B13"},{"key":"2021121003550012200_B14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-199401000-00002","article-title":"Streptococcal pharyngitis: the case for penicillin therapy.","volume":"13","author":"Shulman","year":"1994","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003550012200_B15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0002-9343(54)90219-3","article-title":"Symposium on rheumatic heart disease: the role of the streptococcus in the pathogenesis of rheumatic fever.","volume":"17","author":"Catanzaro","year":"1954","journal-title":"Am J Med"},{"key":"2021121003550012200_B16","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/00006454-199912000-00008","article-title":"Susceptibility of group A beta hemolytic streptococci to thirteen antibiotics: examination of 301 strains isolated in the United States between 1994 and 1997.","volume":"18","author":"Kaplan","year":"1999","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003550012200_B17","first-page":"19","article-title":"Pharmacokinetic (PK) variability explains the high microbiological failure rate for single dose ceftriaxone (CTX) for group A streptococcal pharyngitis (GSP).","volume":"69","author":"Blumer","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"2021121003550012200_B18","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/00006454-198509000-00060","article-title":"Benzathine penicillin G for treatment of group A streptococcal pharyngitis: a reappraisal in 1985.","volume":"4","author":"Kaplan","year":"1985","journal-title":"Pediatr Infect Dis"},{"key":"2021121003550012200_B19","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1542\/peds.97.6.989","article-title":"Are the currently recommended doses of benzathine penicillin G adequate for secondary prophylaxis of rheumatic fever?","volume":"97","author":"Currie","year":"1996","journal-title":"Pediatrics"},{"key":"2021121003550012200_B20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00006454-199805000-00006","article-title":"Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades.","volume":"17","author":"Macris","year":"1998","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003550012200_B21","first-page":"326","article-title":"The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract.","volume":"98","author":"Kaplan","year":"1981","journal-title":"J Lab Clin Med"},{"key":"2021121003550012200_B22","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.1985.03350330069024","article-title":"Streptococcal pharyngitis: placebo controlled double-blind evaluation of clinical response to penicillin therapy.","volume":"253","author":"Krober","year":"1985","journal-title":"JAMA"},{"key":"2021121003550012200_B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006454-198401000-00004","article-title":"The effect of penicillin therapy on the symptoms and signs of streptococcal pharyngitis.","volume":"3","author":"Nelson","year":"1984","journal-title":"Pediatr Infect Dis J"},{"key":"2021121003550012200_B24","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/0002-9343(51)90274-4","article-title":"Effect of penicillin and Aureomycin on the natural course of streptococcal tonsillitis and pharyngitis.","volume":"10","author":"Brink","year":"1951","journal-title":"Am J Med"},{"key":"2021121003550012200_B25"},{"key":"2021121003550012200_B26","doi-asserted-by":"crossref","first-page":"12115","DOI":"10.1073\/pnas.91.25.12115","article-title":"Group A streptococci efficiently invade human respiratory epithelial cells.","volume":"91","author":"LaPenta","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2021121003550012200_B27"},{"key":"2021121003550012200_B28","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1542\/peds.104.4.911","article-title":"Potential mechanisms for failure to eradicate group A streptococci from the pharynx.","volume":"104","author":"Gerber","year":"1999","journal-title":"Pediatrics"},{"key":"2021121003550012200_B29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0022-3476(80)80178-8","article-title":"The group A streptococcal upper respiratory tract carrier state: an enigma.","volume":"97","author":"Kaplan","year":"1980","journal-title":"J Pediatr"},{"key":"2021121003550012200_B30","first-page":"352","article-title":"Perplexity and precision in the diagnosis of streptococcal pharyngitis.","volume":"124","author":"Wannamaker","year":"1972","journal-title":"Am J Dis Child"},{"key":"2021121003550012200_B31"},{"key":"2021121003550012200_B32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1542\/peds.11.1.7","article-title":"Comparative effects of penicillin, aureomycin, and terramycin on streptococcal tonsillitis and pharyngitis.","volume":"11","author":"Denny","year":"1953","journal-title":"Pediatrics"},{"key":"2021121003550012200_B33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1542\/peds.69.4.452","article-title":"Serum penicillin concentrations after intramuscular administration of benzathine penicillin G in children.","volume":"69","author":"Ginsburg","year":"1982","journal-title":"Pediatrics"},{"key":"2021121003550012200_B34","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/clinids\/22.4.727","article-title":"Serum levels of penicillin in basic trainees in the US Army who received intramuscular penicillin G benzathine.","volume":"22","author":"Bass","year":"1996","journal-title":"Clin Infect Dis"},{"key":"2021121003550012200_B35","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jama.1952.03680160021005","article-title":"Prophylaxis against group A streptococcal infections in rheumatic fever patients.","volume":"150","author":"Stollerman","year":"1952","journal-title":"JAMA"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/5\/1180\/893157\/pe1101001180.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/5\/1180\/893157\/pe1101001180.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T05:06:02Z","timestamp":1705208762000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/5\/1180\/63743\/Unexplained-Reduced-Microbiological-Efficacy-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11,1]]},"references-count":35,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2001,11,1]]},"published-print":{"date-parts":[[2001,11,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.5.1180","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,11,1]]}}}